Trevena, Inc. (TRVN)
NCM · Common · CUSIP 89532E109
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for TRVN and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
89532E109
Market Cap
Micro Cap
IPO
1/31/2014 · $7.00/share
Business: Trevena, Inc. is a biopharmaceutical company focused on the development and commercialization of novel medicines for patients affected by Central Nervous System (CNS) conditions.

Company Contact

CEO
Carrie L. Bourdow
CFO
Barry Shin
Headquarters
955 Chesterbrook Boulevard, Suite 110, Chesterbrook, PA 19087
Phone
610-354-8840
Investor Relations
Dan Ferry, LifeSci Advisors LLC · 617-430-7576 · daniel@lifesciadvisors.com
SEC EDGAR Filings
View filings »